| Pharmaceutical active ingredients: |
| Dihydroergotamine Mesylate |
| Available forms, composition and doses of DHE: |
| Capsules, Retard; Oral; Dihydroergotamine Mesylate 2.5 mgCapsules, Retard; Oral; Dihydroergotamine Mesylate 5 mg |
| DHE medical category: |
| Human:Antimigraine preparationsSympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CA01 - Dihydroergotamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Ratiopharm |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
DET MS Retard | Dihydroergotamine Mesylate | Shire |
| DET MS Spezial | Dihydroergotamine Mesylate | Shire |
| Detemes | Dihydroergotamine Mesylate | Sanova Pharma |
| Detemes Retard | Dihydroergotamine Mesylate | Sanova Pharma |
| DHE | Dihydroergotamine Mesylate | Alpharma |
| DHE | Dihydroergotamine Mesylate | Valeant Pharmaceuticals |
| Diergo | Dihydroergotamine Mesylate | Novartis |
| Diergospray | Dihydroergotamine Mesylate | Novartis; Centre Specialites Pharmaceutiques |
| Dihydergot | Dihydroergotamine Mesylate | Novartis; Pro Concepta Zug; Sandoz |
| Dihydroergotamine | Dihydroergotamine Mesylate | Amdipharm |